Application 216986
- Type
- NDA
- Sponsor
- GUERBET
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 1.4553GM/3ML (485.1MG/ML) | Yes | Yes |
| 002 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 3.63825GM/7.5ML (485.1MG/ML) | Yes | Yes |
| 003 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 4.851GM/10ML (485.1MG/ML) | Yes | Yes |
| 004 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 7.2765GM/15ML (485.1MG/ML) | Yes | Yes |
| 005 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 14.553GM/30ML (485.1MG/ML) | Yes | Yes |
| 006 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 24.255GM/50ML (485.1MG/ML) | Yes | Yes |
| 007 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 48.51GM/100ML (485.1MG/ML) | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0270-7015 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7015 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7020 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7025 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7030 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7035 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 67684-4230 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4230 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4230 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4231 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4231 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4231 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4232 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4232 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4232 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4233 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4240 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4241 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4242 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4250 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85133 | SUPPL | 2026-02-24 |
| 85112 | SUPPL | 2026-02-24 |
| 85147 | SUPPL | 2026-02-20 |
| 81486 | SUPPL | 2025-03-07 |
| 81466 | SUPPL | 2025-03-06 |
| 79414 | SUPPL | 2024-08-16 |
| 79198 | SUPPL | 2024-07-24 |
| 79184 | SUPPL | 2024-07-24 |
| 77351 | SUPPL | 2024-01-29 |
| 77330 | SUPPL | 2024-01-29 |
| 72429 | ORIG | 2022-10-20 |
| 72139 | ORIG | 2022-09-22 |
| 72127 | ORIG | 2022-09-21 |
| 72126 | ORIG | 2022-09-21 |